NASDAQ:BNGO
BioNano Genomics Stock News
$1.14
+0.0300 (+2.70%)
At Close: May 17, 2024
SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Praxis Genomics, LLC received accreditation from the College of American Pathologists (CAP), ma
SAN DIEGO, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by the Human Genome Structural Variation Consortium (HGSVC) revealing that their
SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the performance and application of its Saphyr system for optical genome mapping are being showcased at
Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update
04:01pm, Thursday, 12'th Nov 2020
Company to host conference call today, November 12, at 4:30 pm ET Company to host conference call today, November 12, at 4:30 pm ET
Multi-Center Evaluation of Bionano Optical Genome Mapping by Cytogenetics Thought Leaders in the US Leads to Recommendation for Bionano's Saphyr to Replace Karyotyping as First-Line Test for Detection and Identification of Structural and Copy Number Variants in Leukemia Patients
06:10pm, Wednesday, 11'th Nov 2020
SAN DIEGO, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study led by cytogenetics experts from the nation's top clinical and cancer centers in
Publication from UCSF shows Bionano's optical genome mapping technology can detect pathogenic variants missed by whole exome sequencing and by chromosomal microarray in patients with rare genetic diso
Top researchers present discoveries in cancer predisposition, neurodegenerative diseases, microdeletion syndromes and other genetic disorders made using Bionano's optical genome mapping technology Top
Bionano Genomics: Intriguing Technology. Troubling Trajectory
02:14pm, Tuesday, 08'th Sep 2020
Today, we look at a very small concern with potentially game changing technology in a fast-growing part of the healthcare market.
Dr. Chaubey is a key opinion leader in cytogenetics who has developed, validated and commercialized dozens of molecular and cytogenetic tests based on next generation sequencing, microarray and COVID-
Stick With BioNano Genomics (BNGO) Stock as Consumable Revenue Growth Accelerates, Says Analyst
10:42pm, Monday, 17'th Aug 2020
2020 is turning out to be a roller-coaster ride for investors of life science company BioNano Genomics (BNGO). Over the past six trading sessions, the share price has declined by 23%. The drop, howeve
Would Shareholders Who Purchased Bionano Genomics'(NASDAQ:BNGO) Stock Year Be Happy With The Share price Today?
04:10pm, Monday, 17'th Aug 2020
It is a pleasure to report that the Bionano Genomics, Inc. (NASDAQ:BNGO) is up 81% in the last quarter. But that...
Bionano Genomics Announces “At-The-Market” Equity Program
12:30pm, Monday, 17'th Aug 2020
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has filed a prospectus with the Securities and Exchange Commission (“SEC”), under which i
Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin on Q2 2020 Results - Earnings Call Transcript
09:15pm, Thursday, 13'th Aug 2020
Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Ashley Robinson - LifeSci Advisors Erik Holmlin - Chief Executive Officer Conferen
Bionano Genomics Reports Second Quarter 2020 Financial Results and Provides Business Update
09:08pm, Thursday, 13'th Aug 2020
Company to host conference call today, Thursday, August 13, at 4:30 pm ETSAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company tha
* In a new study at Children’s Hospital of Los Angeles evaluating children with B-ALL, the most common type of cancer in children, researchers using Saphyr discovered an oncogenic variation that the
